格米尼斯塔丁:来自真菌奥斯托阿克雷莫尼奥米尼 (Austroacremonium gemini) 的新型脱抗生素
Andrew Crombie1, John A Kalaitzis2, Rachel Chen1
1Microbial Screening Technologies, Smithfield, NSW, 2164, Australia.
The Journal of antibiotics
|June 26, 2024
概括
从澳大利亚的真菌中发现了两种新的脱抗生素,geministatins A和B. 这些化合物表现出有前途的抗菌和抗真菌活性,包括对抗抗甲素耐药黄金葡萄球菌 (MRSA).
科学领域:
- 自然产品化学 自然产品化学
- 菌类学 菌类学是指菌类学.
- 药用化学 医学化学
背景情况:
- 菌类是新型生物活性化合物的丰富来源.
- 由于抗菌素耐药性日益增加,寻找新的抗生素至关重要.
- 脱酸是一种具有多种生物活性的二次代谢物.
研究的目的:
- 从真菌*Austroacremonium gemini*中分离和鉴定出新的脱类抗生素.
- 评估分离化合物的抗菌和抗真菌潜力.
主要方法:
- 使用色谱技术分离化合物.
- 通过详细的光谱分析 (NMR,MS) 和化学降解来阐明结构.
- 生物测试以确定对细菌和酵母菌株的最小抑制度 (MIC).
主要成果:
- 确定了两种新的脱抗生素,即geministatins A (1) 和 B (2).
- 降解产生了三种新的类似物 (3-5) 和一种已知的化合物 (6).
- 化合物1,2和6显示出对 * Bacillus subtilis * 和 * Staphylococcus aureus * (包括MRSA) 的显著抗菌活性.
- 化合物4对*Saccharomyces cerevisiae*表现出抗真菌活性.
结论:
- 这种真菌*Austroacremonium gemini*可以产生具有强大的抗菌性能的新型抗生素.
- 格米尼斯塔丁A和B代表了开发新抗菌剂的潜在线索.
- 对作用机制和结构-活动关系的进一步研究是有必要的.
更多相关视频
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.6K
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
11.6K
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
01:23Antimicrobial Proteins
975
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
975
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
00:57Antibiotic Selection
53.0K
Overview
53.0K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
169
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
169